(Q34161050)

English

Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Donald L Trump

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Heather Payne

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Kurt Miller

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Johann S de Bono

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Joe Stephenson

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Howard A Burris

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Faith Nathan

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Maria Taboada

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Thomas Morris

9

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Andreas Hubner

10

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

26 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1264-1275

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Mechanisms leading to the development of hormone-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Endothelin receptors as novel targets in tumor therapy

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

The endothelin axis in urologic tumors: mechanisms of tumor biology and therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

The endothelin axis: emerging role in cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Targeting bone metastasis in prostate cancer with endothelin receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Docetaxel-based combination therapy for castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: a TAX327 study analysis

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

The importance of endothelin-1 for vascular dysfunction in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Final safety and efficacy analysis of the specific endothelin A receptor antagonist zibotentan (ZD4054) in patients with metastatic castration-resistant prostate cancer and bone metastases who were pain-free or mildly symptomatic for pain: a double-

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21342

21 January 2018

Identifiers

10.1002/PROS.21342

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34161050&oldid=1966849228"